ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

MDXG MiMedx Group Inc

6.3989
0.0389 (0.61%)
Apr 23 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
MiMedx Group Inc MDXG NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0389 0.61% 6.3989 20:00:00
Open Price Low Price High Price Close Price Prev Close
6.35 6.29 6.575 6.51 6.36
more quote information »

Recent News

Date Time Source Heading
4/16/202408:00GLOBEMIMEDX to Host First Quarter 2024 Operating and Financial..
3/27/202408:00GLOBEMIMEDX Provides Update on AXIOFILL® Request for Designation..
3/20/202407:00GLOBEMIMEDX Expands Portfolio with Fibrillar Collagen Wound..
3/13/202408:00GLOBEMIMEDX Introduces E-Commerce and Account Management Platform
3/05/202418:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202418:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202418:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202408:11EDGAR2Form 8-K - Current report
3/04/202408:00GLOBEMIMEDX Announces Appointment of Two New Independent..
2/28/202416:22EDGAR2Form 8-K - Current report
2/28/202416:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/28/202416:01GLOBEMIMEDX Announces Fourth Quarter and Full Year 2023 Operating..
2/21/202416:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/20/202415:55EDGAR2Form 144 - Report of proposed sale of securities
2/20/202408:00GLOBEMIMEDX to Present at TD Cowen 44th Annual Health Care..
2/16/202416:37EDGAR2Form 144 - Report of proposed sale of securities
2/16/202416:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/15/202415:11EDGAR2Form 144 - Report of proposed sale of securities
2/14/202416:13EDGAR2Form 144 - Report of proposed sale of securities
2/12/202408:00GLOBEMIMEDX to Host Fourth Quarter and Full Year 2023 Operating..
1/22/202408:09EDGAR2Form 8-K - Current report
1/22/202408:00GLOBEMIMEDX Announces Improved Capital Structure with New Senior..
12/29/202317:00GLOBEMIMEDX Provides AXIOFILL® Update & Reiterates 2023 Full Year..
12/28/202316:30EDGAR2Form 8-K - Current report
12/28/202308:00GLOBEMIMEDX Announces Conversion of Outstanding Series B..
12/27/202316:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/27/202316:42EDGAR2Form SC 13D/A - General statement of acquisition of..
11/22/202317:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202308:14EDGAR2Form 8-K - Current report
11/13/202308:00GLOBEMIMEDX to Participate in Upcoming Investor Conferences
11/02/202308:00GLOBEMIMEDX to Highlight Published Data at SAWC Fall
10/30/202316:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/30/202316:05EDGAR2Form 8-K - Current report
10/30/202316:01GLOBEMIMEDX Announces Third Quarter 2023 Operating and Financial..
10/16/202308:00GLOBEMIMEDX to Host Third Quarter 2023 Operating and Financial..
9/26/202308:00GLOBEMIMEDX Announces Launch of EPIEFFECTâ„¢
9/05/202317:00EDGAR2Form 8-K - Current report
9/05/202308:38EDGAR2Form 8-K - Current report
9/05/202308:00GLOBEMIMEDX to Present at Upcoming Investor Conferences
8/01/202316:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/01/202316:03EDGAR2Form 8-K - Current report
8/01/202316:01GLOBEMIMEDX Announces Second Quarter 2023 Operating and Financial..
7/25/202316:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
7/25/202316:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
7/18/202308:00GLOBEMIMEDX to Host Second Quarter 2023 Operating and Financial..
7/11/202308:30GLOBEMIMEDX Announces Favorable Ruling in Putative Securities..
7/06/202318:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/06/202318:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
7/05/202309:02EDGAR2Form 8-K - Current report
7/05/202308:00GLOBEMIMEDX Appoints Doug Rice as Chief Financial Officer

Your Recent History

Delayed Upgrade Clock